| Financial Year |
March 31 2023 |
| Monetary Funds |
523,328,377.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
57,119,928.39 |
| Accounts Receivable |
191,014,748.76 |
| Advances to Suppliers |
10,288,210.77 |
| Other Receivables |
1,566,726.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
252,709,351.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,345,046.51 |
| Total Current Assets |
1,100,691,031.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
467,481,009.14 |
| Under-construction Projects |
162,584,959.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,935,972.45 |
| R&D expenses |
-- |
| Goodwill |
109,857,150.17 |
| Long-Term Deferred and Prepaid Expenses |
2,917,937.98 |
| Deferred Income Tax Assets |
36,197,634.81 |
| Other Non-Current Assets |
55,296,140.65 |
| Sub-Total of Non-Current Assets |
878,186,278.19 |
| Total Assets |
1,978,877,309.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,374,086.07 |
| Accounts Payable |
131,477,674.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,598,892.88 |
| Taxes Payable |
2,251,364.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,742,527.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,664,310.76 |
| Other Current Liabilities |
460,888.24 |
| Sub-Total of Current Liabilities |
233,317,354.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
423,469.98 |
| Deferred Income Tax Liabilities |
14,055,688.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,646,587.07 |
| Total Liabilities |
311,963,941.27 |
| Paid-In Capital(Or Share Stock) |
164,081,215.00 |
| Capital Surplus |
1,053,087,888.91 |
| Surplus Reserve |
51,494,541.64 |
| LESS:Treasury Stock |
30,746,171.00 |
| Undistributed Profits |
430,880,531.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,666,913,368.28 |
| Owner's Equity（Stockholder's Equity） |
1,666,913,368.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,978,877,309.55 |
